
X4 PHARMACEUTICALS INC
XFORNASDAQ🏆 #2937 by market capEarnings Nov 4US Equity
$4.49▲ $0.21 (+4.79%)
Live1h▲ 1.2%
24h▲ 4.8%
7d▲ 8.2%
14d▲ 12.1%
30d▲ 10.6%
1y▲ 73.8%
🏦Market Cap
$423M
Small Cap
📈Revenue Growth (YoY)
-71.3%
Declining
📊Gross Margin
81.8%
High
💵FCF Margin
—
⚖️P/S Ratio
48.6x
Expensive
Otter Score
66
Fair
📊
Analyst Ratings
Price
$4.49
Total
13
Raised
0
Lowered
1
Avg PT
$11.67
H / L
$12 / $11
| Institution | Action | Rating | Date |
|---|---|---|---|
Stifel | Reiterated | Buy | 2025-12-05 |
HC Wainwright & Co. | Reiterated | Buy | 2025-11-10 |
Cantor Fitzgerald | Reiterated | Overweight | 2025-03-26 |
B. Riley Securities | Downgraded | Buy → Neutral | 2023-12-12 |
Oppenheimer | Reiterated | Outperform | 2023-03-24 |
Piper Sandler | Reiterated | Overweight | 2022-12-12 |
Canaccord Genuity | Reiterated | Buy | 2022-04-05 |
Brookline Capital | Reiterated | Buy | 2020-12-17 |
H.C. Wainwright | Reiterated | Outperform | 2020-05-08 |
B. Riley FBR | Reiterated | Buy | 2020-05-08 |
Citigroup | Reiterated | Buy | 2020-03-26 |
Roth Capital | Reiterated | Buy | 2019-12-18 |
B. Riley | Reiterated | Buy | 2019-12-05 |
One row per institution, most recent rating